## Gene Summary
ARNT (Aryl Hydrocarbon Receptor Nuclear Translocator) is a key transcriptional regulator involved in cellular responses to environmental stressors, such as hypoxia and exposure to certain xenobiotics. It forms heterodimers with several other transcription factors, most famously with AHR (Aryl Hydrocarbon Receptor). The ARNT:AHR complex binds to specific DNA sequences known as xenobiotic response elements (XREs) and initiates the transcription of genes involved in the metabolic breakdown and clearance of xenobiotics. ARNT also interacts with hypoxia-inducible factors (HIFs), primarily HIF-1Î±, to regulate genes important for adaptation to low oxygen conditions.

## Gene Drugs, Diseases, Phenotypes, and Pathways
ARNT is involved in a wide array of biological pathways including the response to xenobiotic substances like dioxins and polycyclic aromatic hydrocarbons, as well as physiological processes related to hypoxia. Disruption in ARNT function can lead to problems with angiogenesis, erythropoiesis, and cellular proliferation, significantly impacting cardiovascular and pulmonary systems. It is also implicated in carcinogenesis through its role in regulating genes that control cell growth and survival. In terms of diseases, ARNT dysfunction or anomalies are linked to certain cancers and potentially to cardiovascular disorders due to its role in response to hypoxia.

## Pharmacogenetics
In the field of pharmacogenetics, ARNT is relevant due to its transcriptional activities in drug metabolism. With its partner AHR, ARNT modulates the expression of various cytochrome P450 enzymes (CYPs), which are critical for the metabolism of many drugs. Therefore, variations in ARNT can influence individual responses to therapeutics, particularly those drugs metabolized by CYP enzymes. For example, the efficiency of cancer therapeutics that require metabolic activation by CYP enzymes can be affected by ARNT expression levels. However, direct pharmacogenetic associations involving specific variants of ARNT affecting drug efficacy or toxicity are not as well-defined and currently an area of active research. Understanding such interactions may guide personalized therapy approaches in context of ARNT-related pathways.